APO Research
Talk to an analyst

APO RESEARCH · REPORT

Molecular Imaging Agents

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Molecular Imaging Agents Market Outlook and Growth Opportunities 2026

20 December 2025199 pages

Choose your research edition.

Industry ResearchMolecular Imaging Agents Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Molecular Imaging Agents Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Molecular Imaging Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Molecular Imaging Agents Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Molecular Imaging Agents Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Molecular Imaging Agents market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Molecular Imaging Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Molecular Imaging Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Molecular Imaging Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Molecular Imaging Agents market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Molecular Imaging Agents market include Eisai, Guerbet, General Electric and Bracco Diagnostic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Molecular Imaging Agents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Molecular Imaging Agents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Molecular Imaging Agents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Molecular Imaging Agents market size, projected growth trends, production technologies, key applications, and end-use industries.

Molecular Imaging Agents Segment by Company

Eisai

Guerbet

General Electric

Bracco Diagnostic

Molecular Imaging Agents Segment by Type

Engineered Protein Fragments

Nanoparticles

Aptamers

Peptides

Small Molecules

Others

Molecular Imaging Agents Segment by Application

Oncology

Cardiology

Gastrointestinal Disorders

Neurology Disorders

Others

Molecular Imaging Agents Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Molecular Imaging Agents status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Molecular Imaging Agents market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Molecular Imaging Agents significant trends, drivers, influence factors in global and regions.

6. To analyze Molecular Imaging Agents competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molecular Imaging Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Molecular Imaging Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molecular Imaging Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Molecular Imaging Agents market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Molecular Imaging Agents industry.

Chapter 3: Detailed analysis of Molecular Imaging Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Molecular Imaging Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Molecular Imaging Agents in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Molecular Imaging Agents Industry Trends Table 2. Molecular Imaging Agents Industry Drivers Table 3. Molecular Imaging Agents Industry Opportunities and Challenges Table 4. Molecular Imaging Agents Industry Restraints Table 5. Global Molecular Imaging Agents Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Molecular Imaging Agents Revenue Share by Company (2021-2026) Table 7. Global Molecular Imaging Agents Sales Volume by Company (K Tons) & (2021-2026) Table 8. Global Molecular Imaging Agents Sales Volume Share by Company (2021-2026) Table 9. Global Molecular Imaging Agents Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Molecular Imaging Agents Company Ranking, (2024-2026) & (USD Million) Table 11. Global Molecular Imaging Agents Key Company Manufacturing Base & Headquarters Table 12. Global Molecular Imaging Agents Company, Product Type & Application Table 13. Global Molecular Imaging Agents Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Molecular Imaging Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Engineered Protein Fragments Table 18. Significant Companies of Nanoparticles Table 19. Significant Companies of Aptamers Table 20. Significant Companies of Peptides Table 21. Significant Companies of Small Molecules Table 22. Significant Companies of Others Table 23. Global Molecular Imaging Agents Sales Volume by Type 2021 VS 2025 VS 2032 (K Tons) Table 24. Global Molecular Imaging Agents Sales Volume by Type (2021-2026) & (K Tons) Table 25. Global Molecular Imaging Agents Sales Volume by Type (2027-2032) & (K Tons) Table 26. Global Molecular Imaging Agents Sales Volume Share by Type (2021-2026) Table 27. Global Molecular Imaging Agents Sales Volume Share by Type (2027-2032) Table 28. Global Molecular Imaging Agents Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Molecular Imaging Agents Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Molecular Imaging Agents Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Molecular Imaging Agents Sales Value Share by Type (2021-2026) Table 32. Global Molecular Imaging Agents Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Oncology Table 34. Significant Companies of Cardiology Table 35. Significant Companies of Gastrointestinal Disorders Table 36. Significant Companies of Neurology Disorders Table 37. Significant Companies of Others Table 38. Global Molecular Imaging Agents Sales Volume by Application 2021 VS 2025 VS 2032 (K Tons) Table 39. Global Molecular Imaging Agents Sales Volume by Application (2021-2026) & (K Tons) Table 40. Global Molecular Imaging Agents Sales Volume by Application (2027-2032) & (K Tons) Table 41. Global Molecular Imaging Agents Sales Volume Share by Application (2021-2026) Table 42. Global Molecular Imaging Agents Sales Volume Share by Application (2027-2032) Table 43. Global Molecular Imaging Agents Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 44. Global Molecular Imaging Agents Sales Value by Application (2021-2026) & (US$ Million) Table 45. Global Molecular Imaging Agents Sales Value by Application (2027-2032) & (US$ Million) Table 46. Global Molecular Imaging Agents Sales Value Share by Application (2021-2026) Table 47. Global Molecular Imaging Agents Sales Value Share by Application (2027-2032) Table 48. Global Molecular Imaging Agents Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Table 49. Global Molecular Imaging Agents Sales by Region (2021-2026) & (K Tons) Table 50. Global Molecular Imaging Agents Sales Market Share by Region (2021-2026) Table 51. Global Molecular Imaging Agents Sales by Region (2027-2032) & (K Tons) Table 52. Global Molecular Imaging Agents Sales Market Share by Region (2027-2032) Table 53. Global Molecular Imaging Agents Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 54. Global Molecular Imaging Agents Sales Value by Region (2021-2026) & (US$ Million) Table 55. Global Molecular Imaging Agents Sales Value Share by Region (2021-2026) Table 56. Global Molecular Imaging Agents Sales Value by Region (2027-2032) & (US$ Million) Table 57. Global Molecular Imaging Agents Sales Value Share by Region (2027-2032) Table 58. Global Molecular Imaging Agents Market Average Price (US$/Ton) by Region (2021-2026) Table 59. Global Molecular Imaging Agents Market Average Price (US$/Ton) by Region (2027-2032) Table 60. Global Molecular Imaging Agents Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Table 61. Global Molecular Imaging Agents Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Molecular Imaging Agents Sales by Country (2021-2026) & (K Tons) Table 63. Global Molecular Imaging Agents Sales Market Share by Country (2021-2026) Table 64. Global Molecular Imaging Agents Sales by Country (2027-2032) & (K Tons) Table 65. Global Molecular Imaging Agents Sales Market Share by Country (2027-2032) Table 66. Global Molecular Imaging Agents Sales Value by Country (2021-2026) & (US$ Million) Table 67. Global Molecular Imaging Agents Sales Value Market Share by Country (2021-2026) Table 68. Global Molecular Imaging Agents Sales Value by Country (2027-2032) & (US$ Million) Table 69. Global Molecular Imaging Agents Sales Value Market Share by Country (2027-2032) Table 70. Eisai Company Information Table 71. Eisai Business Overview Table 72. Eisai Molecular Imaging Agents Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 73. Eisai Molecular Imaging Agents Product Portfolio Table 74. Eisai Recent Development Table 75. Guerbet Company Information Table 76. Guerbet Business Overview Table 77. Guerbet Molecular Imaging Agents Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. Guerbet Molecular Imaging Agents Product Portfolio Table 79. Guerbet Recent Development Table 80. General Electric Company Information Table 81. General Electric Business Overview Table 82. General Electric Molecular Imaging Agents Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 83. General Electric Molecular Imaging Agents Product Portfolio Table 84. General Electric Recent Development Table 85. Bracco Diagnostic Company Information Table 86. Bracco Diagnostic Business Overview Table 87. Bracco Diagnostic Molecular Imaging Agents Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 88. Bracco Diagnostic Molecular Imaging Agents Product Portfolio Table 89. Bracco Diagnostic Recent Development Table 90. Key Raw Materials Table 91. Raw Materials Key Suppliers Table 92. Molecular Imaging Agents Distributors List Table 93. Molecular Imaging Agents Customers List Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Molecular Imaging Agents Product Image Figure 2. Global Molecular Imaging Agents Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Molecular Imaging Agents Sales Value (2021-2032) & (US$ Million) Figure 4. Global Molecular Imaging Agents Sales (2021-2032) & (K Tons) Figure 5. Global Molecular Imaging Agents Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Molecular Imaging Agents Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Engineered Protein Fragments Image Figure 10. Nanoparticles Image Figure 11. Aptamers Image Figure 12. Peptides Image Figure 13. Small Molecules Image Figure 14. Others Image Figure 15. Global Molecular Imaging Agents Sales Volume by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 16. Global Molecular Imaging Agents Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Molecular Imaging Agents Sales Volume Share by Type (2021-2032) Figure 18. Global Molecular Imaging Agents Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Molecular Imaging Agents Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Molecular Imaging Agents Sales Value Share by Type (2021-2032) Figure 21. Oncology Image Figure 22. Cardiology Image Figure 23. Gastrointestinal Disorders Image Figure 24. Neurology Disorders Image Figure 25. Others Image Figure 26. Global Molecular Imaging Agents Sales Volume by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 27. Global Molecular Imaging Agents Sales Volume Share 2021 VS 2025 VS 2032 Figure 28. Global Molecular Imaging Agents Sales Volume Share by Application (2021-2032) Figure 29. Global Molecular Imaging Agents Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Molecular Imaging Agents Sales Value Share 2021 VS 2025 VS 2032 Figure 31. Global Molecular Imaging Agents Sales Value Share by Application (2021-2032) Figure 32. Global Molecular Imaging Agents Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Figure 33. Global Molecular Imaging Agents Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 34. Global Molecular Imaging Agents Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 35. Global Molecular Imaging Agents Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 36. North America Molecular Imaging Agents Sales Value (2021-2032) & (US$ Million) Figure 37. North America Molecular Imaging Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Europe Molecular Imaging Agents Sales Value (2021-2032) & (US$ Million) Figure 39. Europe Molecular Imaging Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Asia-Pacific Molecular Imaging Agents Sales Value (2021-2032) & (US$ Million) Figure 41. Asia-Pacific Molecular Imaging Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 42. South America Molecular Imaging Agents Sales Value (2021-2032) & (US$ Million) Figure 43. South America Molecular Imaging Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 44. Middle East & Africa Molecular Imaging Agents Sales Value (2021-2032) & (US$ Million) Figure 45. Middle East & Africa Molecular Imaging Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 46. USA Molecular Imaging Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. USA Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. USA Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Canada Molecular Imaging Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Canada Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Canada Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Mexico Molecular Imaging Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Mexico Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Mexico Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Germany Molecular Imaging Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Germany Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Germany Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. France Molecular Imaging Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. France Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. France Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. U.K. Molecular Imaging Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. U.K. Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. U.K. Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Italy Molecular Imaging Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Italy Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Italy Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Spain Molecular Imaging Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Spain Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Spain Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Russia Molecular Imaging Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Russia Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Russia Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Netherlands Molecular Imaging Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Netherlands Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Netherlands Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Nordic Countries Molecular Imaging Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Nordic Countries Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Nordic Countries Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. China Molecular Imaging Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. China Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. China Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Japan Molecular Imaging Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Japan Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Japan Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. South Korea Molecular Imaging Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. South Korea Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. South Korea Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. India Molecular Imaging Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. India Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. India Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Australia Molecular Imaging Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Australia Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Australia Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Southeast Asia Molecular Imaging Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Southeast Asia Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Southeast Asia Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Brazil Molecular Imaging Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Brazil Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Brazil Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Argentina Molecular Imaging Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Argentina Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Argentina Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Chile Molecular Imaging Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Chile Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Chile Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Colombia Molecular Imaging Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Colombia Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Colombia Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Peru Molecular Imaging Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Peru Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Peru Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Molecular Imaging Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Saudi Arabia Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Saudi Arabia Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Israel Molecular Imaging Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Israel Arabia Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Israel Arabia Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. UAE Molecular Imaging Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. UAE Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. UAE Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Turkey Molecular Imaging Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Turkey Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Turkey Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Iran Molecular Imaging Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Iran Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Iran Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Egypt Molecular Imaging Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 128. Egypt Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 129. Egypt Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 130. Molecular Imaging Agents Value Chain Figure 131. Manufacturing Cost Structure Figure 132. Molecular Imaging Agents Sales Mode & Process Figure 133. Direct Comparison with Distribution Share Figure 134. Distributors Profiles Figure 135. Years Considered Figure 136. Research Process Figure 137. Key Executives Interviewed

Scope & coverage.

Types
  • Engineered Protein Fragments
  • Nanoparticles
  • Aptamers
  • Peptides
  • Small Molecules
  • Others
Applications
  • Oncology
  • Cardiology
  • Gastrointestinal Disorders
  • Neurology Disorders
  • Others
Companies covered
  • Eisai
  • Guerbet
  • General Electric
  • Bracco Diagnostic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Molecular Imaging Agents Sales Value (2021-2032)
  4. 1.2.2 Global Molecular Imaging Agents Sales Volume (2021-2032)
  5. 1.2.3 Global Molecular Imaging Agents Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Molecular Imaging Agents Market Dynamics
  1. 2.1 Molecular Imaging Agents Industry Trends
  2. 2.2 Molecular Imaging Agents Industry Drivers
  3. 2.3 Molecular Imaging Agents Industry Opportunities and Challenges
  4. 2.4 Molecular Imaging Agents Industry Restraints
3 Molecular Imaging Agents Market by Company
  1. 3.1 Global Molecular Imaging Agents Company Revenue Ranking in 2025
  2. 3.2 Global Molecular Imaging Agents Revenue by Company (2021-2026)
  3. 3.3 Global Molecular Imaging Agents Sales Volume by Company (2021-2026)
  4. 3.4 Global Molecular Imaging Agents Average Price by Company (2021-2026)
  5. 3.5 Global Molecular Imaging Agents Company Ranking (2024-2026)
  6. 3.6 Global Molecular Imaging Agents Company Manufacturing Base and Headquarters
  7. 3.7 Global Molecular Imaging Agents Company Product Type and Application
  8. 3.8 Global Molecular Imaging Agents Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Molecular Imaging Agents Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Molecular Imaging Agents Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Molecular Imaging Agents Market by Type
  1. 4.1 Molecular Imaging Agents Type Introduction
  2. 4.1.1 Engineered Protein Fragments
  3. 4.1.2 Nanoparticles
  4. 4.1.3 Aptamers
  5. 4.1.4 Peptides
  6. 4.1.5 Small Molecules
  7. 4.1.6 Others
  8. 4.2 Global Molecular Imaging Agents Sales Volume by Type
  9. 4.2.1 Global Molecular Imaging Agents Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Molecular Imaging Agents Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Molecular Imaging Agents Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Molecular Imaging Agents Sales Value by Type
  13. 4.3.1 Global Molecular Imaging Agents Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Molecular Imaging Agents Sales Value by Type (2021-2032)
  15. 4.3.3 Global Molecular Imaging Agents Sales Value Share by Type (2021-2032)
5 Molecular Imaging Agents Market by Application
  1. 5.1 Molecular Imaging Agents Application Introduction
  2. 5.1.1 Oncology
  3. 5.1.2 Cardiology
  4. 5.1.3 Gastrointestinal Disorders
  5. 5.1.4 Neurology Disorders
  6. 5.1.5 Others
  7. 5.2 Global Molecular Imaging Agents Sales Volume by Application
  8. 5.2.1 Global Molecular Imaging Agents Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Molecular Imaging Agents Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Molecular Imaging Agents Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Molecular Imaging Agents Sales Value by Application
  12. 5.3.1 Global Molecular Imaging Agents Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Molecular Imaging Agents Sales Value by Application (2021-2032)
  14. 5.3.3 Global Molecular Imaging Agents Sales Value Share by Application (2021-2032)
6 Molecular Imaging Agents Regional Sales and Value Analysis
  1. 6.1 Global Molecular Imaging Agents Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Molecular Imaging Agents Sales by Region (2021-2032)
  3. 6.2.1 Global Molecular Imaging Agents Sales by Region: 2021-2026
  4. 6.2.2 Global Molecular Imaging Agents Sales by Region (2027-2032)
  5. 6.3 Global Molecular Imaging Agents Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Molecular Imaging Agents Sales Value by Region (2021-2032)
  7. 6.4.1 Global Molecular Imaging Agents Sales Value by Region: 2021-2026
  8. 6.4.2 Global Molecular Imaging Agents Sales Value by Region (2027-2032)
  9. 6.5 Global Molecular Imaging Agents Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Molecular Imaging Agents Sales Value (2021-2032)
  12. 6.6.2 North America Molecular Imaging Agents Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Molecular Imaging Agents Sales Value (2021-2032)
  15. 6.7.2 Europe Molecular Imaging Agents Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Molecular Imaging Agents Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Molecular Imaging Agents Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Molecular Imaging Agents Sales Value (2021-2032)
  21. 6.9.2 South America Molecular Imaging Agents Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Molecular Imaging Agents Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Molecular Imaging Agents Sales Value Share by Country, 2025 VS 2032
7 Molecular Imaging Agents Country-level Sales and Value Analysis
  1. 7.1 Global Molecular Imaging Agents Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Molecular Imaging Agents Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Molecular Imaging Agents Sales by Country (2021-2032)
  4. 7.3.1 Global Molecular Imaging Agents Sales by Country (2021-2026)
  5. 7.3.2 Global Molecular Imaging Agents Sales by Country (2027-2032)
  6. 7.4 Global Molecular Imaging Agents Sales Value by Country (2021-2032)
  7. 7.4.1 Global Molecular Imaging Agents Sales Value by Country (2021-2026)
  8. 7.4.2 Global Molecular Imaging Agents Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Molecular Imaging Agents Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Molecular Imaging Agents Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Molecular Imaging Agents Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Molecular Imaging Agents Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Molecular Imaging Agents Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Molecular Imaging Agents Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Molecular Imaging Agents Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Molecular Imaging Agents Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Molecular Imaging Agents Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Molecular Imaging Agents Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Molecular Imaging Agents Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Molecular Imaging Agents Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Molecular Imaging Agents Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Molecular Imaging Agents Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Molecular Imaging Agents Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Molecular Imaging Agents Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Molecular Imaging Agents Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Molecular Imaging Agents Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Molecular Imaging Agents Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Molecular Imaging Agents Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Molecular Imaging Agents Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Molecular Imaging Agents Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Molecular Imaging Agents Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Molecular Imaging Agents Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Molecular Imaging Agents Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Molecular Imaging Agents Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Molecular Imaging Agents Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Molecular Imaging Agents Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Molecular Imaging Agents Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Molecular Imaging Agents Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eisai
  2. 8.1.1 Eisai Company Information
  3. 8.1.2 Eisai Business Overview
  4. 8.1.3 Eisai Molecular Imaging Agents Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Eisai Molecular Imaging Agents Product Portfolio
  6. 8.1.5 Eisai Recent Developments
  7. 8.2 Guerbet
  8. 8.2.1 Guerbet Company Information
  9. 8.2.2 Guerbet Business Overview
  10. 8.2.3 Guerbet Molecular Imaging Agents Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Guerbet Molecular Imaging Agents Product Portfolio
  12. 8.2.5 Guerbet Recent Developments
  13. 8.3 General Electric
  14. 8.3.1 General Electric Company Information
  15. 8.3.2 General Electric Business Overview
  16. 8.3.3 General Electric Molecular Imaging Agents Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 General Electric Molecular Imaging Agents Product Portfolio
  18. 8.3.5 General Electric Recent Developments
  19. 8.4 Bracco Diagnostic
  20. 8.4.1 Bracco Diagnostic Company Information
  21. 8.4.2 Bracco Diagnostic Business Overview
  22. 8.4.3 Bracco Diagnostic Molecular Imaging Agents Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Bracco Diagnostic Molecular Imaging Agents Product Portfolio
  24. 8.4.5 Bracco Diagnostic Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Molecular Imaging Agents Value Chain Analysis
  2. 9.1.1 Molecular Imaging Agents Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Molecular Imaging Agents Sales Mode & Process
  6. 9.2 Molecular Imaging Agents Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Molecular Imaging Agents Distributors
  9. 9.2.3 Molecular Imaging Agents Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst